Critical

Vasopressin as a catecholamine-sparing adjunct in septic shock

Second-line vasopressor · Shock / Sepsis
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Adding fixed-dose vasopressin to noradrenaline in septic shock to reduce catecholamine requirement and restore vascular tone via V1 receptors, exploiting the relative vasopressin deficiency of sepsis. Given at a fixed rate, not titrated.

Red flags

  • Rising dose despite combination therapy (refractory shock)
  • New digital cyanosis or mottling
  • Abdominal pain / rising lactate suggesting mesenteric ischaemia
  • Bradycardia or falling cardiac output
  • Attempting to titrate vasopressin upward for hypotension

Assessment

Differential diagnosis

  • Catecholamine-resistant septic shock
  • Vasoplegia (post-cardiopulmonary bypass, liver failure)
  • Mixed septic/cardiogenic shock
  • Occult hypovolaemia
  • Adrenal insufficiency contributing to shock

Investigations

  • Serial lactate and ScvO2
  • Arterial line for continuous MAP
  • U&E, LFTs, bilirubin (digital/mesenteric ischaemia risk)
  • Echocardiography to exclude low cardiac output
  • Cumulative noradrenaline dose trend

Management

  • Confirm adequate fluid resuscitation and that noradrenaline is already running (typically ≥0.25-0.5 mcg/kg/min)
  • Add fixed-dose vasopressin as a catecholamine-sparing agent, not as a titratable pressor
  • Do not up-titrate vasopressin beyond the recommended ceiling to chase MAP — adjust noradrenaline instead
  • Reassess perfusion (lactate clearance, urine output, capillary refill) after 1-2 h
  • Monitor for digital, mesenteric and cardiac ischaemia
  • Wean noradrenaline first once stable, leaving vasopressin until last or per unit protocol
  • Consider adding hydrocortisone if shock remains vasopressor-dependent

Drugs & doses

Vasopressin — 20 units in 50 mL 0.9% saline (0.4 units/mL), run at 0.03 units/min fixed (4.5 mL/h); do not exceed 0.04 units/min
Noradrenaline — 0.05-1 mcg/kg/min IV titrated to MAP ≥65 mmHg (background agent)
Hydrocortisone — 50 mg IV QDS (or 200 mg/24 h infusion) if vasopressor-dependent

Disposition

Manage in critical care with invasive monitoring; wean catecholamines before vasopressin unless local protocol dictates otherwise.

Complications & pitfalls

  • Peripheral/digital ischaemia and skin necrosis
  • Mesenteric ischaemia
  • Reduced cardiac output / coronary vasoconstriction
  • Hyponatraemia
  • Rebound hypotension on abrupt discontinuation

Exam pearls

  • Vasopressin is dosed, not titrated — fixed at 0.03 units/min
  • Its catecholamine-sparing effect lowers noradrenaline-related arrhythmia and tachycardia burden
  • Introduce it earlier rather than at maximal noradrenaline for best sparing effect
  • Watch the fingers and gut — ischaemia is the characteristic toxicity

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.